Piperazine based cytofectins
US6022874A · kind A · utility
41Cited by
10References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 23, 1998 |
| Grant date | Feb 8, 2000 |
| Priority date | — |
| Expiry date | Dec 23, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/812
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to piperazine based amphilic cationic lipids useful for gene therapy, transfection, and introducing immunogenic compounds for the purpose of vaccination. The disclosed compounds have lipophilic moieties linked to the ring nitrogens. In addition, at least one of the ring nitrogens is quatranized and linked to a hydrocarbon having at least one heteroatom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.